SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-24-008706
Filing Date
2024-05-09
Accepted
2024-05-09 16:30:28
Documents
19
Period of Report
2024-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 p582408k.htm   iXBRL 8-K 43836
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 120569
3 EXHIBIT 4.1 ex4_1.htm EX-4.1 87318
4 EXHIBIT 10.1 ex10_1.htm EX-10.1 299126
5 EXHIBIT 10.2 ex10_2.htm EX-10.2 163770
6 EXHIBIT 99.1 ex99_1.htm EX-99.1 12862
10 GRAPHIC alzamendlogo_regmark.jpg GRAPHIC 17222
  Complete submission text file 0001214659-24-008706.txt   1100685

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE alzn-20240509.xsd EX-101.SCH 2991
8 XBRL LABEL FILE alzn-20240509_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE alzn-20240509_pre.xml EX-101.PRE 22343
22 EXTRACTED XBRL INSTANCE DOCUMENT p582408k_htm.xml XML 3914
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40483 | Film No.: 24931213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)